Monarch Therapeutics is an adoptive cell therapy company that is revolutionizing cell therapies. With a focus on solid tumors, Monarch Therapeutics implements its universal platform which works to eliminate tumors that are targeted by its differentiated adaptors that enable industryleading tunability, multiplexing, and control. Monarch Therapeutics is set to drive multiple pipeline candidates through IND-enabling studies.